{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T05:27:32Z","timestamp":1793165252960,"version":"4.5.0"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T00:00:00Z","timestamp":1667174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>To develop quality indicators (QIs) for the evaluation of the prevention and management of cancer therapy-related cardiovascular toxicity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>We followed the European Society of Cardiology (ESC) methodology for QI development which comprises (i) identifying the key domains of care for the prevention and management of cancer therapy-related cardiovascular toxicity in patients on cancer treatment, (ii) performing a systematic review of the literature to develop candidate QIs, and (iii) selecting of the final set of QIs using a modified Delphi process. Work was undertaken in parallel with the writing of the 2022 ESC Guidelines on Cardio-Oncology and in collaboration with the European Haematology Association, the European Society for Therapeutic Radiology and Oncology and the International Cardio-Oncology Society. In total, 5 main and 9 secondary QIs were selected across five domains of care: (i) Structural framework, (ii) Baseline cardiovascular risk assessment, (iii) Cancer therapy related cardiovascular toxicity, (iv) Predictors of outcomes, and (v) Monitoring of cardiovascular complications during cancer therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We present the ESC Cardio-Oncology QIs with their development process and provide an overview of the scientific rationale for their selection. These indicators are aimed at quantifying and improving the adherence to guideline-recommended clinical practice and improving patient outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ehjqcco\/qcac070","type":"journal-article","created":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T08:33:15Z","timestamp":1666341195000},"page":"1-7","source":"Crossref","is-referenced-by-count":41,"title":["European Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatment"],"prefix":"10.1093","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6385-8600","authenticated-orcid":false,"given":"G A","family":"Lee","sequence":"first","affiliation":[{"name":"Division of Applied Technology for Clinical Care, Florence Nightingale Faculty of Nursing, Midwifery & Palliative Care, King's College London , James Clerk Maxwell Building, 57 Waterloo Road, London SE1 8WA ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9854-481X","authenticated-orcid":false,"given":"S","family":"Aktaa","sequence":"additional","affiliation":[{"name":"Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds , Leeds ,","place":["UK"]},{"name":"Leeds Institute for Data Analytics, University of Leeds , Leeds ,","place":["UK"]},{"name":"Department of Cardiology, Leeds Teaching Hospitals NHS Trust , Leeds ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Baker","sequence":"additional","affiliation":[{"name":"Division of Applied Technology for Clinical Care, Florence Nightingale Faculty of Nursing, Midwifery & Palliative Care, King's College London , James Clerk Maxwell Building, 57 Waterloo Road, London SE1 8WA ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C P","family":"Gale","sequence":"additional","affiliation":[{"name":"Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds , Leeds ,","place":["UK"]},{"name":"Leeds Institute for Data Analytics, University of Leeds , Leeds ,","place":["UK"]},{"name":"Department of Cardiology, Leeds Teaching Hospitals NHS Trust , Leeds ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israa F","family":"Yaseen","sequence":"additional","affiliation":[{"name":"Baghdad Heart Center, Baghdad Teaching Hospital, Medical City , Baghdad ,","place":["Iraq"]},{"name":"Scientific Council of Cardiology, Iraqi Board for Medical Specializations , Baghdad ,","place":["Iraq"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1316-8676","authenticated-orcid":false,"given":"G","family":"Gulati","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, University of Oslo, Oslo, Norway, Division of Research and Innovation, Akershus University Hospital , L\u00f8renskog ,","place":["Norway"]},{"name":"Department of Cardiology, Division of Medicine, Oslo University Hospital , Ullev\u00e5l, Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2273-7228","authenticated-orcid":false,"given":"R","family":"Asteggiano","sequence":"additional","affiliation":[{"name":"School of Medicine, Insubria University , Varese ,","place":["Italy"]},{"name":"LARC (Laboratorio Analisi e Ricerca Clinica) , C.so Venezia 10, Turin ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3075-1943","authenticated-orcid":false,"given":"S","family":"Szmit","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Circulation, Thromboembolic Diseases and Cardiology, Centre of Postgraduate Medical Education , Otwock ,","place":["Poland"]},{"name":"Institute of Hematology and Transfusion Medicine , Warsaw ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1055-2231","authenticated-orcid":false,"given":"A","family":"Cohen-Solal","sequence":"additional","affiliation":[{"name":"Research Medical Unit INSERM U-942, University of Paris , Paris ,","place":["France"]},{"name":"Cardiology Department, H\u00f4pitaux de Paris , H\u00f4pital Lariboisi\u00e8re 2 Rue Ambroise Par\u00e9 , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Abdin","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, Cardiology, Angiology, Intensive Care Medicine, Saarland University Medical Center , Homburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Jurczak","sequence":"additional","affiliation":[{"name":"MSC National Research Institute of Oncology , Garnarska 11, 31-115 Krakow ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5899-6125","authenticated-orcid":false,"given":"P","family":"Garrido Lopez","sequence":"additional","affiliation":[{"name":"Jefe Servicio Oncolog\u00eda M\u00e9dica, Hospital Universitario Ram\u00f3n y Cajal , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A L","family":"Sverdlov","sequence":"additional","affiliation":[{"name":"Newcastle Centre of Excellence in Cardio-Oncology, Calvary Mater Newcastle, Hunter Medical Research Institute, John Hunter Hospital, University of Newcastle , NSW ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C G","family":"Tocchetti","sequence":"additional","affiliation":[{"name":"Cardio-Oncology Unit, Department of Translational Medical Sciences (DISMET), Center for Basic and Clinical Immunology Research (CISI), Interdepartmental Center for Clinical and Translational Research (CIRCET), Interdepartmental Hypertension Research Center (CIRIAPA), Federico II University , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9935-8904","authenticated-orcid":false,"given":"A","family":"Barac","sequence":"additional","affiliation":[{"name":"Cardio-oncology Program, MedStar Heart and Vascular Institute , Washington DC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Parrini","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Mauriziano Hospital , Turin ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Zamorano","sequence":"additional","affiliation":[{"name":"University Hospital Ramon y Cajal , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Iakobishvili","sequence":"additional","affiliation":[{"name":"Department of Community Cardiology, Clalit Health Services, Tel Aviv Jaffa , Israel"},{"name":"Faculty of Health Sciences, Ben Gurion University of the Negev , Beersheba ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Pudil","sequence":"additional","affiliation":[{"name":"University Hospital Hradec Kr\u00e1lov\u00e9 , Sokolsk\u00e1 5005, Hradec Kr\u00e1lov\u00e9 ,","place":["Czech Republic"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Badimon","sequence":"additional","affiliation":[{"name":"IIBSant Pau, Hospital de la Santa Creu i Sant Pau, CiberCV , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A M","family":"Kirby","sequence":"additional","affiliation":[{"name":"Royal Marsden NHS Trust & Institute of Cancer Research , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5433-4810","authenticated-orcid":false,"given":"A H","family":"Blaes","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology\/Transplantation, University of Minnesota , Minneapolis, MN ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8364-3447","authenticated-orcid":false,"given":"D","family":"Farmakis","sequence":"additional","affiliation":[{"name":"University of Cyprus Medical School , Nicosia ,","place":["Cyprus"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Curigliano","sequence":"additional","affiliation":[{"name":"Department of Oncology and Hemato-Oncology, University of Milan , Milan ,","place":["Italy"]},{"name":"IRCCS, European Institute of Oncology , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Stephens","sequence":"additional","affiliation":[{"name":"Patient Advocate , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A R","family":"Lyon","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute, Imperial College London, and Cardio-Oncology Service, Royal Brompton Hospital , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Lopez-Fernandez","sequence":"additional","affiliation":[{"name":"Cardiology department, La Paz University Hospital, IdiPAZ Research Institute , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,10,31]]},"reference":[{"key":"2026080909364185300_bib1","first-page":"947","article-title":"Evaluation and management of cancer patients presenting with acute cardiovascular disease: a consensus document of the Acute CardioVascular Care (ACVC) association and the ESC council of Cardio-Oncology\u2014Part 1: acute coronary syndromes and acute pericardial diseases","volume":"10","author":"Gevaert","year":"2021","journal-title":"EHJ Acute CV Care"},{"key":"2026080909364185300_bib2","article-title":"Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Consensus Document of the Acute CardioVascular Care (ACVC) association and the ESC council of Cardio-Oncology - Part 2: Acute Heart Failure, Acute myocardial diseases, Acute Venous Thromboembolic Diseases and Acute Arrhythmias","author":"Gevaert","year":"2022","journal-title":"EHJ Acute CV Care"},{"key":"2026080909364185300_bib3","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","article-title":"ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)","volume":"37","author":"Zamorano","year":"2016","journal-title":"Eur Heart J"},{"key":"2026080909364185300_bib4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/ehjqcco\/qcaa069","article-title":"European Society of Cardiology methodology for the development of quality indicators for the quantification of cardiovascular care and outcomes","volume":"8","author":"Aktaa","year":"2022","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2026080909364185300_bib5","first-page":"ehac244","article-title":"2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS): Developed by the task force on cardio-oncology of the European Society of Cardiology (ESC)","author":"Lyon","year":"2022","journal-title":"EHJ"},{"key":"2026080909364185300_bib6","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"2026080909364185300_bib7","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1093\/eurheartj\/ehaa006","article-title":"on behalf of the CARDIOTOX Registry Investigators, Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registry","volume":"41","author":"L\u00f3pez-Send\u00f3n","year":"2020","journal-title":"Eur Heart J"},{"key":"2026080909364185300_bib8","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1002\/ijc.32908","article-title":"Cardiac mortality after radiotherapy, chemotherapy and endocrine therapy for breast cancer: Cohort study of 2 million women from 57 cancer registries in 22 countries","volume":"147","author":"Henson","year":"2020","journal-title":"Int J Cancer"},{"key":"2026080909364185300_bib9","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1002\/ejhf.1920","article-title":"Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society","volume":"22","author":"Lyon","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2026080909364185300_bib10","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s10549-022-06515-5","article-title":"Trends in heart disease mortality among breast cancer survivors in the US, 1975-2017","volume":"192","author":"Vo","year":"2022","journal-title":"Breast Cancer Res Treat"},{"key":"2026080909364185300_bib11","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1093\/eurheartj\/ehab843","article-title":"A systematic review and meta-analysis of beta-blockers and renin\u2014angiotensin system inhibitors for preventing left ventricular dysfunction due to anthracyclines or trastuzumab in patients with breast cancer","volume":"43","author":"Lewinter","year":"2022","journal-title":"Eur Heart J"},{"key":"2026080909364185300_bib12","first-page":"ehab368","article-title":"ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2026080909364185300_bib13","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/ejhf.2371","article-title":"European Society of Cardiology quality indicators for the care and outcomes of adults with heart failure. Developed by the Working Group for Heart Failure Quality Indicators in collaboration with the Heart Failure Association of the European Society of Cardiology","volume":"24","author":"Aktaa","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2026080909364185300_bib14","doi-asserted-by":"publisher","first-page":"847012","DOI":"10.3389\/fcvm.2022.847012","article-title":"Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms and Strategies for Cardioprotection","volume":"9","author":"Morelli","year":"2022","journal-title":"FRONT CARDIOVASC MED"},{"key":"2026080909364185300_bib15","doi-asserted-by":"crossref","first-page":"14637","DOI":"10.1038\/s41598-021-94127-2","article-title":"Arterial hypertension assessment in a population with chronic myeloid leukemia","volume":"11","author":"Roa-Chamorro","year":"2021","journal-title":"Sci Rep"},{"key":"2026080909364185300_bib16","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/eurjpc\/zwaa054","article-title":"Anticoagulation in patients with atrial fibrillation and active cancer: an international survey on patient management","volume":"28","author":"Boriani","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"2026080909364185300_bib17","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/ehjqcco\/qcaa039","article-title":"Shared decision making\u2014The patient on the forefront of care coordination","volume":"6","author":"Hendriks","year":"2020","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2026080909364185300_bib18","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/eurheartj\/ehz935","article-title":"Cardiology care delivered to cancer patients: The results of a questionnaire survey by the Council for Cardio Oncology and Council for Cardiology Practice of the European Society of Cardiology","volume":"41","author":"Asteggiano","year":"2020","journal-title":"Eur Heart J"},{"key":"2026080909364185300_bib19","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1093\/eurheartj\/ehy453","article-title":"Cardio-Oncology Services: rationale, organization, and implementation: A report from the ESC Cardio-Oncology council","volume":"40","author":"Lancellotti","year":"2019","journal-title":"Eur Heart J"}],"container-title":["European Heart Journal - Quality of Care and Clinical Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjqcco\/advance-article-pdf\/doi\/10.1093\/ehjqcco\/qcac070\/47248214\/qcac070.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjqcco\/article-pdf\/9\/1\/1\/48360531\/qcac070.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjqcco\/article-pdf\/9\/1\/1\/48360531\/qcac070.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T13:36:52Z","timestamp":1786282612000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjqcco\/article\/9\/1\/1\/6783158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,31]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,10,31]]},"published-print":{"date-parts":[[2022,12,13]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjqcco\/qcac070","relation":{},"ISSN":["2058-5225","2058-1742"],"issn-type":[{"value":"2058-5225","type":"print"},{"value":"2058-1742","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,1]]},"published":{"date-parts":[[2022,10,31]]}}}